Vir Biotechnology appoints Jason O’Byrne as CFO

Vir Biotechnology (VIR) announced that Jason O’Byrne was appointed as executive VP and CFO, effective October 2. O’Byrne will join the Vir executive management team and report directly to the company’s CEO, Marianne De Backer. O’Byrne is an accomplished executive with more than 20 years of experience in finance and operations. O’Byrne joins Vir from Caribou Biosciences (CRBU), where he served as CFO leading the finance, investor relations, corporate communications, IT, procurement and operations functions as the company advanced its pipeline of clinical-stage cell therapies in oncology and autoimmune disease.